What's breaking now, across thousands of outlets.
Roivant Sciences on Wednesday checked off another milestone in its attempt to build a franchise drug in autoimmune diseases. The biotech said two trials for brepocitinib, which won its first approval earlier ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Respiratory virus surveillance in the WHO African Region Epidemiological Week 41 October 5 to 11 2026 orlunwop@who.int Wed, 21/10/2026 - 15:34 During Epiweek 41, 19 countries in the WHO African region…
GSK has won FDA approval for its hepatitis B drug, which extended functional cures to far more patients than previous methods.
Annual campaign highlights education, patient choice and access to breast reconstruction Arlington Heights, Ill, Oct. 21, 2026 (GLOBE NEWSWIRE) — The American Society of Plastic Surgeons (ASPS), in…
Former art teacher, who cared for her disabled son, ‘received almost no support’, said her local MP Manuela Perteghella Andy Burnham has backed mandatory suicide prevention training for social workers…
Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, researchers from the MRC Laboratory of Medical Sciences (LMS), the University…
[Shabelle] Mogadishu -- Somalia's leading telecommunications company Hormuud Telecom on Tuesday hosted the fifth edition of the Somalia's Success Story Forum (BGS26) in Mogadishu, bringing together…
